DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Zalutumumab
Zalutumumab
MEDICAL Injectables & ONCOLOGY TREND REPORT™
Nimotuzumab, an Antitumor Antibody That Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding While Permitting the Active Receptor Conformation
Targeted and Novel Therapy in Advanced Gastric Cancer Julie H
Download
The Antibody Zalutumumab Inhibits Epidermal Growth Factor Receptor Signaling by Limiting Intra- and Intermolecular Flexibility
The Two Tontti Tudiul Lui Hi Ha Unit
The Erbb/HER Family of Protein-Tyrosine Kinases and Cancer
High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody-Drug Conjugates Bart ECG De Goeij1, David Sa
Application of Molecular Targeted Therapies in the Treatment of Head and Neck Squamous Cell Carcinoma (Review)
Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma Paul Gougis , Camille Moreau Bachelard, Maud Kamal, Hui K
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
INN Working Document 05.179 Update December 2010
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Use of Pyrimidine Derivatives for the Treatment of EGFR Dependent Diseases Or Diseases That Have Acquired Resistance to Agents That Target EGFR Family Members
(INN) for Biological and Biotechnological Substances
Top View
The Effects of Flow on Therapeutic Protein Aggregation
Mini Review MOLECULARLY TARGETING the PI3K-Akt-Mtor
Hypomagnesemia in the Cancer Patient
| Hao Hata Kata Tai Mit on a Man Taiwan Ta Material
Human Igg2 Antibodies Against Epidermal Growth Factor Receptor
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Emerging Drugs for Head and Neck Cancer
Myeloid Lineage But, in Contrast to Igg1, Only by Cells of Antibody
The Role of Targeted Molecular Inhibitors in the Management of Advanced Nonmelanoma Skin Cancer Kevin W
Innovative Therapeutic Strategies in the Treatment of Meningioma
Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
Mtor Inhibitor PKI-587 Enhances Sensitivity to Cetuximab in EGFR-Resistant Human Head and Neck Cancer Models
Cutaneous Squamous Cell Carcinoma: from Biology to Therapy
Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: the Rationale for Combination Therapies
Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
Emerging Strategies Against Head & Neck Cancer
(2006.01) C07d 413/14
Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
( 12 ) Patent Application Publication
Molecular Targeting Therapy Against EGFR Family in Breast Cancer: Progress and Future Potentials
Genmab Initiates Study of Zalutumumab with Radiotherapy in Head and Neck Cancer
EGFR and C-Met Inhibitors Are Effective in Reducing
Radiotherapy Plus EGFR Inhibitors: Synergistic Modalities Paolo Bossi1* and Francesca Platini2
Critical Issues in Head and Neck Oncology
EGFR) Antibodies Are Not Affected by Lung Cancer-Associated EGFR Kinase Mutations This Information Is Current As of September 29, 2021
Oncompass Report NÉV Anonymous a Realtime Oncology Molecular Treatment Calculator Számításaival
Inhibition Cells Insensitive to EGFR Signaling in Inhibiting Tumorigenesis, Even of Tumor Cellular Cytotoxicity Plays a Prominen
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
(INN) for Biological and Biotechnological Substances
Ep 3088005 A1
Truncated Epiderimal Growth Factor Receptor (Egfrt) for Transduced T Cell Selection
Oncompass Report NÉV Anonymous a Realtime Oncology Molecular Treatment Calculator Számításaival
Invasion-Related Factors As Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma—A Review
Assessment of the Evolution of Cancer Treatment Therapies
Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy
Cell-Centric View of Apoptosis and Apoptotic Cell Death-Inducing Antitumoral Strategies
Monoclonal Antibodies and Fc Fragments for Treating Solid Tumors
Comprehensive Analysis of Mutation-Based and Expressed Genes-Based Pathways in Head and Neck Squamous Cell Carcinoma
Review Article Biologic Therapy in Head and Neck Cancer: a Road with Hurdles
(Chemo)- Radiation